Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)

The Statement works through a small set of legal‑administrative concepts that determine how it will be applied in claims decision‑making. Those concepts, as used in the instrument, are the diagnostic concept (what the condition is), the reasonable hypothesis threshold (what must be shown), the enumerated factors (what counts as relevant evidence), temporal and exposure thresholds, and the relationship to service.

Diagnostic concept: Section 6(2) sets a two‑part diagnostic requirement for "ulnar neuropathy at the elbow": clinical features (altered sensation, pain or weakness in the ulnar distribution) and electrodiagnostic evidence confirming impaired nerve conduction across the elbow. This is not merely descriptive; it functions as the medical standard the decision‑maker will look for in records when the condition is claimed.

Reasonable hypothesis threshold: The instrument is explicitly framed to identify when a "reasonable hypothesis" has been raised. Section 7 begins: "At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised..." The Statement therefore sets a minimum evidentiary bar: presence of any one enumerated factor (properly related to service under s 8) suffices to meet that bar. The Statement does not itself adjudicate causation beyond this threshold , it supplies a criterion used in the statutory decision framework referenced in s 3.

Enumerated factors: Sections 7(1)-7(45) are the operative list. They are grouped by type and by whether they relate to initial clinical onset or to clinical worsening. The list includes:

• Direct local trauma or fracture to the affected elbow (7(1), 7(2), 7(23), 7(24));
• Repetitive and forceful activities involving elbow flexion/extension with precise exposure minima (90 hours within six months, not ceased more than 30 days before onset/worsening) (7(3), 7(25));
• Holding tools or devices with specific wrist/elbow postures with identical cumulative thresholds (7(4), 7(26));
• Using the elbow as a support in specific postures for defined periods (7(5), 7(27));
• Surgical events under general anaesthesia or procedures to the affected elbow with defined look‑back windows (7(6), 7(7), 7(28), 7(29));
• Hospitalisation or bed confinement (two days within 30 days prior) (7(8), 7(30));
• Mobility‑related exposures (daily self‑propulsion of a manual wheelchair, or use of elbow/forearm crutches, with 60 hours within six months thresholds) (7(9), 7(11), 7(31), 7(33));
• Comorbidities and medical conditions (paraplegia, inflammatory/degenerative joint diseases involving the elbow, amyloidosis, dialysis, cerebrovascular accident with hemiplegia, diabetes mellitus, acromegaly) (7(10), 7(12), 7(13), 7(14), 7(15), 7(21), 7(22), 7(35), 7(36), 7(37), 7(43), 7(44));
• External burns requiring hospitalisation, pregnancy, infection of the ulnar nerve, smoking exposure (pack‑years), and compressive lesions (7(16)-7(20), 7(39)-7(42));
• A final stated factor, inability to obtain appropriate clinical management for the condition (7(45)).

Temporal and exposure thresholds: Several factors contain explicit temporal windows and minimum exposure amounts. Examples: repetitive and forceful activities require cumulative 90 hours in a six‑month window with cessation no more than 30 days before onset/worsening (7(3), 7(25)); wheelchair propulsion and crutch use require 60 hours in six months with similar cessation rules (7(9), 7(11), 7(31), 7(33)); surgery under general anaesthesia within two months before onset/worsening (7(6), 7(28)); elbow surgery within one year (7(7), 7(29)); hospitalisation or supine bed confinement for at least two days within 30 days before onset/worsening (7(8), 7(30)). Those thresholds are definitional inputs to whether a factor is present.

Relationship to service: Section 8 requires that any factor referred to in s 7 "must be related to the relevant service rendered by the person." Schedule 1 defines "relevant service" to include operational, peacekeeping, hazardous, British nuclear test defence service under the VEA, and warlike and non‑warlike service under the MRCA. Additionally, s 8(2) limits how factors 23-45 operate: they are confined to situations where the person already suffered or contracted ulnar neuropathy before or during service (but the condition did not arise out of service), and then the factors may establish material contribution to, or aggravation of, the condition.

Cross‑reference mechanism: Section 9 provides that where an enumerated factor refers to an injury or disease for which another Statement of Principles exists, the relevant factors in that other Statement apply according to its terms. This creates an operational dependency between Statements where comorbid or causal conditions overlap.

Definitions are operational: Schedule 1 contains detailed definitions that are actively invoked in the criteria (for example, "trauma to the affected elbow" contains a multi‑part test with time constraints; "pack‑years" is precisely defined; "lesion as specified" is an inclusive list). These definitions convert broad clinical notions into administrable tests for claims assessment.

In short, the Statement converts the RMA's stated medical view into a rule‑set that decision‑makers under the VEA/MRCA use to determine whether the minimum factual and medical conditions exist to support a reasonable hypothesis linking ulnar neuropathy at the elbow to relevant service.

Primary parties affected by this Statement are claimants (veterans, members of Peacekeeping Forces, or members of the Forces covered by the VEA or MRCA) who lodge claims for ulnar neuropathy at the elbow or death from that condition under the statutory provisions identified in s 3. Section 3 expressly states the instrument applies to claims to which s 120A of the VEA or s 338 of the MRCA apply; the Statement is therefore directed at the adjudicative processes used in those claim categories.

Decision‑makers and administrators are directly affected. The Repatriation Medical Authority made the Statement (s 2) and supplies the medical criteria; decision‑makers within the claims framework under the VEA and MRCA will apply the Statement when assessing whether a reasonable hypothesis is raised. Section 9 also brings other Statements of Principles into play where a listed factor refers to a separate injury or disease that has its own Statement , that means administrative practitioners exercising claims decisions must cross‑check other Statements and apply them "in accordance with the terms of that Statement of Principles as in force from time to time."

Healthcare providers and medical experts who prepare reports for claims will be affected functionally: the Statement specifies that electrodiagnostic confirmation is required to meet the definition of ulnar neuropathy at the elbow (s 6(2)(b)). Clinicians’ reports will therefore need to supply that evidence to be aligned with the Statement’s definition. Surgeons, rehabilitation providers, radiologists, and other treating clinicians will be relied upon to document surgical procedures, hospital stays, presence of lesions, comorbid conditions (for example, diabetes, amyloidosis, acromegaly), infections, and smoking history.

Unit and workplace record‑keepers may be affected when claimants rely on service records or duty logs to show exposure to repetitive and forceful activities (for example, cumulative hours of lifting, use of power tools, climbing ladders, ammunitioning, or overhead throwing) or posture‑specific activities (holding tools with wrist extended, elbow flexed; using the elbow as support). The Statement lists specific examples which suggest the kinds of activity logs that will be relevant (see s 7(3) note and s 7(5) note).

Third‑party evidence holders are also implicated: hospital records (for burn hospitalisation, surgical procedures, bed confinement), imaging or operative reports for lesions (Schedule 1 lesion as specified), dialysis records, dialysis duration, pathology reports, EMG/nerve conduction studies for electrodiagnostic confirmation, and public health records for smoking history may all be relevant. The inclusion of "inability to obtain appropriate clinical management" (s 7(45)) may involve records evidencing attempts to access care and reasons for inability to obtain it.

Indirectly affected groups include insurers and private employers, to the extent that claimants’ service activities or post‑service employment expose them to the enumerated activities. The Statement does not regulate employers or private insurers, but it establishes administrative criteria that may affect whether a claimant is eligible for veterans’ entitlements in cases with occupational exposure overlap.

Finally, the Statement affects legal practitioners, advocates and medical experts who prepare and present claims. The instrument dictates which facts and types of evidence are central to raising a reasonable hypothesis; practitioners must align evidence collection, clinical opinions and legal submissions with the instrument’s thresholds and definitions.

The instrument does not itself create criminal or civil liabilities for third parties, nor does it purport to alter private contractual relations. It is an administrative tool within the veterans’ statutory compensation and rehabilitation framework.

The Statement imposes no duties or rights in the sense of obligations enforced by penalties inside the instrument itself. Instead, it establishes evidentiary duties and thresholds that claimants and decision‑makers must observe in the course of administrative determinations under the VEA and MRCA.

Evidentiary duty on claimants: Practically, a claimant seeking to have ulnar neuropathy at the elbow, or death from it, accepted as related to relevant service must adduce sufficient material to show at least one of the factors listed in s 7. Section 7 frames the list as the minimum that "must as a minimum exist before it can be said that a reasonable hypothesis has been raised." Therefore the claim’s initial evidentiary duty is to link the claimant’s medical condition to at least one enumerated factor, and then to show that the factor is related to relevant service (s 8(1)).

Medical evidence duty: The Statement requires electrodiagnostic confirmation for the diagnosis (s 6(2)(b)). The RMA’s definition therefore imposes a practical duty to produce EMG/nerve conduction studies or equivalent electrodiagnostic evidence if the claimant and advising clinicians want the condition to fall within the Statement’s definition.

Temporal and exposure proof: For many factors, the claimant must prove specific exposure thresholds and time windows. Examples include cumulative hours (90 hours in six months for repetitive forceful activities or holding tools; 60 hours in six months for wheelchair propulsion or crutch use), time‑since‑exposure ceilings (the activity "has not ceased more than 30 days before the clinical onset" or clinical worsening), and surgical or hospitalisation look‑backs (two months for general anaesthesia; one year for elbow surgery; two days in the 30 days for supine hospital bed confinement). These are factual elements claimants must establish.

Duty to show relation to service: Section 8(1) requires that the existence of any factor in s 7 "must be related to the relevant service rendered by the person." That allocates to the claimant the burden of showing a causal or temporal nexus between the factor and the veteran's service. The Schedule defines "relevant service" categories; therefore the claimant must show the factor occurred in a context that falls within those service categories.

Narrowed operation for pre‑existing conditions: Section 8(2) changes the legal test for factors 23-45: those factors only operate as evidence of material contribution to, or aggravation of, ulnar neuropathy when the person’s condition pre‑dated or began during service (but did not arise out of service). This introduces an additional evidentiary duty: if relying on factors 23-45, the claimant must prove a pre‑existing condition and then show material contribution or aggravation.

Cross‑Statement duties: Section 9 places an obligation on decision‑makers to apply other Statements of Principles where an enumerated factor refers to another injury or disease that itself has a Statement. The effect is that decision‑makers must consult and apply the terms of those other Statements "as in force from time to time."

Rights of decision‑makers: The instrument is a tool for decision‑makers within the veterans’ entitlements system; it grants them a concretely articulated set of criteria to determine whether a reasonable hypothesis has been raised. The RMA’s role in making the Statement is explicit (s 2). The Statement, therefore, shapes decision‑makers’ rights to accept or reject causal inferences on particular, enumerated factual grounds.

No penalties or enforcement powers in the instrument: The Statement does not create offences, fines, or administrative penalties. It is not itself an instrument of enforcement; enforcement mechanisms and consequences (for example, grant or denial of benefits) flow from the underlying statutes (VEA and MRCA) and the decisions of administrators and tribunals applying those Acts using this Statement.

Procedural implication: Because the Statement sets minimum criteria for raising a reasonable hypothesis, failure to satisfy any of the factors set out (or to link them to relevant service) will, insofar as decision‑makers follow the Statement, tend to result in the reasonable hypothesis threshold not being met. That is a pragmatic effect on claim outcomes, and therefore affects claimants' procedural position and evidentiary strategy.

In sum, the Statement creates duties of proof and evidence alignment for claimants and medical advisers, and it clarifies how decision‑makers are to treat specific kinds of factual and medical material in assessing whether a reasonable hypothesis of service connection exists.

The Statement of Principles itself contains no penal provisions, enforcement mechanisms or remedies. It is an administrative instrument produced under subsection 196B(2) of the VEA (s 2) and designed to be applied in the statutory claims framework specified in s 3. Consequently, any penalties, enforcement actions, or remedial consequences arising from application of the Statement are external to the instrument and derive from the VEA, the MRCA, and the administrative decision‑making and review processes established by those Acts.

Immediate enforcement reality under the Statement:

• The Statement operates as a determinative evidentiary instrument used by decision‑makers to assess whether the threshold of a "reasonable hypothesis" linking ulnar neuropathy at the elbow to relevant service is met. A decision to accept or reject entitlement on that basis will follow the rules and processes of the VEA or MRCA. The Statement does not itself specify how decisions are to be implemented, appealed, or reviewed; those functions reside in the parent Acts and in the administrative procedures set by the relevant agencies.
• Because there are no fines or criminal penalties in the Statement, it cannot directly sanction non‑compliance by clinicians, claimants or record‑keepers. Its "teeth" are procedural: if a claimant cannot establish one of the enumerated factors (properly related to service) and the decision‑maker adheres to the Statement, the claimant’s reasonable hypothesis will not be raised, and the claim may be refused under the statutory benefit schema. That is an administrative consequence rather than a statutory penalty imposed by the Statement itself.

Enforcement actors and discretion:

• The Repatriation Medical Authority is the author of the Statement (s 2) and supplies the criteria. The Statement requires decision‑makers under the VEA/MRCA to use it when determining whether a reasonable hypothesis has been raised for claims identified in s 3. The instrument does not, however, constrain how other discretionary elements of claims decisions are exercised where those elements are governed by statute or regulation; it supplies specifically the criteria around the reasonable hypothesis question.
• Section 9 requires that where a listed factor refers to an injury or disease covered by another Statement of Principles, that other Statement applies "in accordance with the terms of that Statement ... as in force from time to time." This imposes an enforcement obligation on decision‑makers to take into account the current terms of other Statements.

Proof and evidentiary standard:

• The Statement sets minimum factual and medical elements for the reasonable hypothesis standard. The question of whether those factual elements are satisfied in any particular case is decided by the claims decision‑maker, using the evidence available. The Statement therefore affects enforcement by narrowing or clarifying what evidence will be accepted as sufficient to meet the reasonable hypothesis threshold.

Remedies and review:

• The Statement does not specify remedies or review routes. Remedies for claim rejection, or review mechanisms for decisions that apply the Statement, are governed by the VEA and MRCA, and by the administrative review and judicial review processes those statutes and the general law provide. The Statement itself contains no litigation guidance, appeal rights or enforcement procedures.

Record and amendment implications:

• The compilation notes and endnotes record amendments up to Amendment No. 44 of 2020, with the amendment to the definition of "trauma to the affected elbow" appearing in Schedule 1 (endnote 4). The instrument’s continued force depends on its statutory underpinning; any changes to the VEA/MRCA or to the RMA’s determinations will affect how the Statement is enforced in practice.

In short, enforcement of the Statement’s criteria occurs indirectly through the claims decision process under the VEA and MRCA, not via penalties created in the Statement itself. The practical enforcement consequence is that failing to satisfy the Statement’s criteria makes a reasonable hypothesis lesslikely to be found by the decision‑maker, and therefore affects entitlement outcomes under the parent statutes.

The Statement is an instrument made under subsection 196B(2) of the Veterans' Entitlements Act 1986 (VEA) (s 2). It is expressly designed to be applied in determinations under provisions from two statutes: section 120A of the VEA and section 338 of the Military Rehabilitation and Compensation Act 2004 (MRCA) (s 3). The instrument therefore sits inside and operates through those statutory frameworks, although the instrument itself does not reproduce or amend those statutory sections.

Direct statutory interaction:

• The Statement supplies the RMA’s medical criteria that decision‑makers implementing s 120A VEA or s 338 MRCA will use when assessing whether a reasonable hypothesis has been raised. The instrument’s applicability is statutory: it applies to claims to which those particular sections apply (s 3). The Statement does not purport to alter the substantive entitlements in the VEA or MRCA; it supplies the operational test for one element of the decision‑making process , the reasonable hypothesis question.

Cross‑Statement interaction:

• Section 9 creates an operational cross‑reference mechanism: if a factor in s 7 refers to an injury or disease that itself has a Statement of Principles determined under s 196B(2) of the VEA, the decision‑maker must apply the factors in that other Statement "in accordance with the terms of that Statement of Principles as in force from time to time." This requires claim assessors to read the Statements and to apply the terms of other Statements where factors overlap (for example, when enumerated factors include comorbidities such as diabetes mellitus, amyloidosis, or inflammatory joint diseases for which separate Statements may exist). The net effect is that the RMA’s Statements of Principles operate as an interlocking set of evidentiary tools across the veterans’ claims regime.

Definitions and statute coherence:

• Schedule 1 defines "VEA" and "MRCA" and gives detailed medical and exposure definitions that are to be used in conjunction with the parent statutes. For example, "relevant service" is defined in Schedule 1 as encompassing a range of service types under the VEA and MRCA (operational, peacekeeping, hazardous, British nuclear test defence, warlike and non‑warlike service). This ensures that the Statement’s factors are interpreted in the context of the statutory categories of service that give rise to potential entitlements.

Amendment and temporal interaction:

• The compilation endnotes show the amending instrument (Amendment No. 44 of 2020) and its commencement date (25 May 2020). The Statement therefore interacts with the legislative process; decision‑makers must apply the Statement in its current, in‑force form, and attend to amendment history where relevant to the claim at hand. Section 9’s cross‑reference to other Statements "as in force from time to time" implicitly requires claim adjudicators to apply the current law or the law in force at the relevant time as dictated by the statutory framework and any transitional provisions (the compilation includes notes on uncommenced amendments and application/saving/transitional provisions).

Administrative law and review:

• While the instrument itself does not provide appeal routes, its use in the VEA/MRCA decision‑making process means that administrative law principles, statutory review mechanisms, and tribunal/judicial review processes relevant to those statutes will govern how decisions that rely on this Statement are reviewed. The Statement therefore interacts indirectly with administrative law remedies and principles of procedural fairness and reasoned decision‑making applied to determinations under the parent Acts.

No conflict with criminal law or general public law powers:

• The Statement does not engage criminal law nor does it purport to displace general public law obligations; it is focused on evidentiary criteria within the veterans’ entitlement statutory framework.

Limitation on extrinsic reliance:

• The Statement’s own text frames its evidentiary role; it does not expand statutory definitions or create new categories of service. Where a factor mentions an injury or disease with its own Statement, s 9 directs application of that other Statement, rather than the present instrument attempting to subsume or alter the terms of that separate Statement.

Operational implication for counsel and practitioners:

• Lawyers and advisers must combine the instrument’s criteria with the substantive and procedural rules in the VEA and MRCA. The Statement supplies a precise set of factual tests and definitions that are intended to be applied within those statutory decision frameworks.

In sum, the Statement is an administrative evidentiary instrument that sits inside and is applied through the VEA and MRCA claims processes, cross‑links with other RMA Statements of Principles where comorbid conditions or related injuries are referenced, and is subject to amendment and the general rules of administrative law applicable to decisions under those statutes.

The compilation includes the original Statement of Principles (No. 65 of 2017) made on 3 November 2017 and commencing on 4 December 2017 (s 1, s 2). The endnotes record legislative history and amendments up to Amendment Statement of Principles (No. 44 of 2020). The amending instrument (No. 44 of 2020) was registered on 28 April 2020 and commenced on 25 May 2020 (endnote 3). The compilation notes that the day of commencement of that amendment is 25 May 2020.

The amendment history entry in the endnotes (Endnote 4) identifies a specific amendment to Schedule 1 , namely the definition of "trauma to the affected elbow" , which was replaced or revised by the No. 44 of 2020 amending Statement. The amendment history table records: "Schedule 1 - Dictionary - trauma to the affected elbow……… rs. No. 44 of 2020." The "rs" abbreviation denotes "repealed and substituted". Therefore, the Schedule’s multi‑part definition of trauma to the affected elbow appearing in this compilation reflects the substitution effected by the 2020 amendment.

The compilation instructions at the front also flag that uncommenced amendments, if any, are not shown, and that modifications by other laws may affect operation without amending the instrument text as compiled. The endnotes include standard compilation commentary (Endnote 1,About the endnotes; Endnote 2,Abbreviation key) which explains how misdescribed amendments are handled and how amendment details are annotated.

Key practical points from the recorded amendment history:

• The principal amendment recorded in the endnotes (No. 44 of 2020) affects the Schedule 1 definition of "trauma to the affected elbow." The definition in the current compilation is therefore the post‑2020 definition and should be taken as authoritative for claims whose relevant dates fall after the commencement of that amendment, to the extent that no transitional provisions alter its temporal application (no transitional provisions are included in this instrument; the compilation notes that any application, saving or transitional provision not included would be recorded in the endnotes).
• No other section‑level amendments are recorded in the endnotes; the legislative history table lists the original Statement (No. 65 of 2017) and the amending Statement (No. 44 of 2020).

Implications for practitioners:

• Practitioners must check the series page on the Legislation Register for any uncommenced amendments or further amendments not contained in this compiled text (the compilation notes advise this). The instrument contains the endnotes that show amendments up to the compilation date of 25 May 2020. Where a claim straddles amendment dates (for example, an event before and an onset after an amendment), practitioners should consider whether the parent statutes or administrative practice require application of the Statement as in force at a particular point in time. The Statement itself does not set out transitional rules.

Administrative housekeeping:

• The Statement provides the RMA’s medical criteria as they stood on the compilation date. The RMA is the competent authority to issue further Statements or amendments under subsection 196B(2) of the VEA. Any future changes to medical evidence or policy would be introduced through subsequent RMA determinations and recorded as amending instruments in the endnotes and the legislation register.

In short, the compilation records one substantive amendment up to 25 May 2020 , replacement of the Schedule 1 definition of "trauma to the affected elbow" by Amendment No. 44 of 2020. Users should consult the legislation register and RMA publications for any later amendments or uncommenced changes.

The instrument as compiled does not record any judicial or tribunal decisions, nor does it cite or list any litigation that interprets or challenges the Statement. The Statement itself contains no litigation history section. The only legal history recorded in the compilation is the administrative amendment history (Endnote 3 and Endnote 4), which documents the making and amendment of the Statement (No. 65 of 2017 and Amendment No. 44 of 2020), and the usual compilation endnotes explaining the register and amendment annotations.

Practical implications from the absence of recorded litigation in the instrument:

• The Statement does not include references to cases, and no case law is mentioned in the text. That absence should be read literally: the RMA’s Statement is presented as a technical administrative instrument setting out medical factors and definitions, not as a judicially interpreted statute in the compilation itself.
• Where claimants or decision‑makers contest whether the Statement has been correctly applied in a particular claims decision, litigation or tribunal review may follow from the decision under the VEA or MRCA. However the Statement contains no record of such litigation. To assess any litigation history that interprets, applies, or challenges the Statement, practitioners must search tribunal and court records beyond this instrument; the instrument itself provides no curated case list.

Points to consider for any potential litigation context:

• The Statement sets factual thresholds and definitions that decision‑makers will use. Litigation challenging a decision that applied the Statement would typically focus on whether the decision‑maker correctly applied the Statement’s criteria, whether the medical evidence met the Statement’s defined requirements (for example, presence of electrodiagnostic evidence), and whether the required nexus to relevant service (s 8) was established. The Statement itself does not establish procedural standards for review; those are supplied by the VEA, MRCA and the general law of administrative review.
• Section 9 points to reliance on other Statements of Principles where a factor refers to another injury or disease. Litigation could potentially arise over which Statement applies or over how multiple Statements should be harmonised in assessing causation, but no such litigation is recorded in the compiled instrument.

Accordingly, the compiled text contains no litigation history. Practitioners needing to understand how tribunals or courts have dealt with the Statement in practice must undertake external case law research and tribunal decision searches.

The Statement contains numerous technical features and precise thresholds that create traps for the unprepared claimant or adviser. These "gotchas" are grounded in the statutory text and Schedule definitions; they will materially affect whether a factor is found to exist and whether it is properly related to relevant service.

1. Diagnosis requires electrodiagnostic confirmation (s 6(2)(b)). The RMA’s definition of ulnar neuropathy at the elbow requires both clinical features and electrodiagnostic evidence "that confirms impaired ulnar nerve conduction across the elbow." Absent that electrodiagnostic evidence, the condition , for the purposes of this Statement , is not within the defined term. Practitioners should not rely on clinical symptoms alone.

2. Temporal windows and cessation rules are strict. Several factors require that the implicated activity "has not ceased more than 30 days before the clinical onset" or clinical worsening (see 7(3)(b), 7(4)(b), 7(5)(c), 7(25)(b), 7(26)(b), 7(27)(c), and corresponding worsening provisions). If an activity ceased 31 days prior, the factor as worded will not be met. The look‑back windows and cessation rules are mechanical and can defeat a factor if the timing is not documented precisely.

3. Cumulative exposure thresholds must be met exactly. For repetitive and forceful activities and similar exposure factors, the instrument requires cumulative thresholds (90 hours in a continuous six‑month period for some activities, 60 hours in six months for wheelchair/crutch use). Vague testimony about prolonged or repetitive use is unlikely to meet the stated test without records showing the cumulative exposure.

4. The definition of "trauma to the affected elbow" is detailed and multi‑part (Schedule 1). It requires a discrete event applying significant physical force, symptom development within 24 hours, persistence of symptoms for at least seven days, and recognises exceptions where medical intervention alters the symptom timeline. If a claimant’s trauma does not meet all elements, the trauma factor in s 7(2) and s 7(24) will not be satisfied.

5. Smoking threshold is specific and temporally conditional (7(19), 7(41)). The instrument requires at least ten pack‑years, smoking that commenced at least five years before onset/worsening, and a five‑year window for cessation where relevant. The Schedule defines pack‑years with precise weight‑based conversions. Partial or unclear smoking histories may fall short of the factor.

6. Factors 23-45 are limited to aggravation/material contribution when the ulnar neuropathy pre‑existed (s 8(2)). These factors do not establish initial causation if the condition arose out of service; rather they operate to show material contribution or aggravation when the condition predated service or was suffered during service but did not arise out of it. Failure to demonstrate the pre‑existing condition will therefore disqualify reliance on these factors.

7. "Inability to obtain appropriate clinical management" is an enumerated factor (7(45)). This is potentially amorphous. The Statement provides no definition of "appropriate clinical management" within the instrument; practitioners will need to establish, with supporting records, what attempts at care were made and why they failed. That evidentiary burden can be challenging, and the factor’s vagueness may produce discretionary assessment issues.

8. Comorbidity and overlapping Statements: Section 9 directs that where a factor refers to another injury or disease covered by a different Statement, that other Statement applies. Practically, this can generate complexity: a claimant relying on, for example, diabetes mellitus (7(21)) may need to align evidence with the separate Statement on diabetes (if one exists). Practitioners should not assume that proving diabetes alone is sufficient; they must check any relevant separate Statement and its specific factors.

9. Lesion as specified is broad but defined (Schedule 1). The Schedule lists many lesion types (benign or malignant neoplasm, bony fragment, calcification, cyst, ganglion, gouty tophus, haemorrhage/haematoma, lymphoedema, scar, tuberculoma, or other pathological lesion). However, mere imaging noting a non‑compressive abnormality may not suffice; the factor requires a lesion that "compresses or displaces" the ulnar nerve at the time of onset or worsening (7(20), 7(42)). The clinician’s interpretation and imaging correlation are therefore essential.

10. Surgical and anaesthetic timing is precise. General anaesthesia within two months and elbow surgery within one year before onset/worsening are enumerated. Claims where surgery or anaesthesia falls outside those windows will not meet the factor.

11. Paraplegia and cerebrovascular accident inclusions have qualifications. For cerebrovascular accident the instrument excludes transient ischaemic attack or "transient symptoms with infarction" (7(15), 7(37)). Practitioners must therefore ensure accurate neurological diagnoses are recorded.

12. Death linkage requires contribution to a terminal event (s 6(3)). Death from ulnar neuropathy includes death from a terminal event or condition that was "contributed to by the person's ulnar neuropathy at the elbow." The Schedule defines "terminal event" as proximate or ultimate causes of death and provides examples (pneumonia, respiratory failure, cardiac arrest, circulatory failure, cessation of brain function). Establishing contribution to such terminal events will require robust evidence.

13. Examples in the notes do not replace the test. The instrument includes illustrative notes (for example, examples of repetitive activities, notes on lesion definitions and infection examples). These are explanatory but the operative legal tests are those in the sections and Schedule. Relying on an example alone without meeting the explicit element requirements is a risk.

14. Record convergence requirement. The Statement’s operational success hinges on documentary support: electrodiagnostic tests, operation notes, hospitalisation records, service activity logs, duty records, and detailed smoking history. Absence or fragmentation of records is a predictable practical obstacle.

15. Date of application and amendments: the compilation records the amendment to the trauma definition (No. 44 of 2020). Practitioners must ensure they apply the correct version of the definition that applies to the dates and circumstances in each claim, and check for later amendments or transitional arrangements not recorded here.

Each of these points arises directly from the text. Practitioners should therefore translate the factor wording and Schedule definitions into precise evidence collection strategies; failure to do so is the principal operational gotcha.

If you are advising a claimant, preparing a claim, or representing a decision‑maker, the Statement points to a discrete evidence‑collection and presentation plan. Compliance means assembling the specific types of proof the Statement requires, aligning them with the precise thresholds, and linking the proven factor to the veteran’s relevant service (s 8(1)). Below is a practical, source‑grounded checklist and guidance drawn from the instrument’s text and Schedule definitions.

1. Confirm the diagnosis to the Statement’s standard

• Obtain and include electrodiagnostic evidence confirming impaired ulnar nerve conduction across the elbow (s 6(2)(b)). This is an explicit definitional element and is not optional for the Statement’s operation.
• Document clinical features: altered sensation, pain or weakness in the ulnar nerve distribution (s 6(2)(a)).

2. Determine whether the claim concerns initial clinical onset or clinical worsening

• The Statement differentiates factors that relate to clinical onset and those that relate to clinical worsening (s 7). Carefully identify the relevant clinical date(s) and ensure records clearly record onset and any subsequent worsening episodes.

3. Map the claim to one or more enumerated factors in section 7

• Go through factors 1-45 and identify which factor(s) the claimant’s circumstances match. Note that only one factor is required to raise a reasonable hypothesis, but the stronger the convergence of multiple factors the better the evidential posture.
• For activity‑based factors (7(3), 7(4), 7(5), 7(25)-7(27), 7(31), 7(33)), document cumulative exposure amounts and continuous periods: e.g., 90 hours in six months for repetitive/forceful activities or tool‑holding; 60 hours in six months for wheelchair propulsion/crutch use. Show that activities "have not ceased more than 30 days before" the clinical onset/worsening where that is required.

4. Collect temporally precise records

• Surgical records and anaesthesia records demonstrating timing relative to onset (general anaesthesia within two months, elbow surgery within one year) (7(6), 7(7), 7(28), 7(29)).
• Hospitalisation records showing confinement to bed in supine position for at least two days within 30 days before onset/worsening (7(8), 7(30)).
• Duty logs, unit records, personnel or workplace task rosters documenting the nature, duration and dates of repetitive or forceful activities (examples listed in the Statement’s notes), and posture‑specific tasks (7(3) note, 7(5) note).
• For trauma to the elbow, record the discrete event, immediate symptom onset within 24 hours, persistence for at least seven days or evidence of medical intervention specified in Schedule 1 (definition of "trauma to the affected elbow").

5. Document comorbidities and lesion evidence

• For factors involving inflammatory/degenerative joint disease, amyloidosis, diabetes mellitus, acromegaly, paraplegia, dialysis, infection, burns, cerebrovascular accident with hemiplegia, obtain specialist reports, pathology, imaging and treatment histories as required (s 7, Schedule 1).
• For "lesion as specified," obtain imaging (MRI, ultrasound, CT), biopsy or operative findings to show a lesion that compresses or displaces the ulnar nerve (Schedule 1 list).

6. Smoking history precision

• Where smoking is relied on, calculate pack‑years according to Schedule 1. Show commencement date and cessation date if relevant to the five‑year conditions in s 7(19) and 7(41).

7. Show relationship to relevant service

• Document how the proven factor was related to the veteran’s relevant service (s 8(1)). This may require showing that tasks were undertaken as part of service duties, that an injury occurred while rendering relevant service, or that exposure during service meets the factor criteria. Use service medical records, incident reports, unit logs, mate testimony, or employer statements as appropriate.

8. If relying on factors 23-45, show pre‑existing condition and nexus

• For material contribution or aggravation under 8(2), prove that the ulnar neuropathy was suffered or contracted before or during service (but did not arise out of service) and then show how the factor materially contributed to or aggravated the condition.

9. Address "inability to obtain appropriate clinical management"

• For factor 7(45), document attempts to access care, dates, providers contacted, reasons care was unavailable or inappropriate, and any expert commentary on how that failure would contribute to onset or worsening.

10. Cross‑check other Statements of Principles (s 9)

• If an enumerated factor references another disease that has its own Statement, obtain the relevant Statement and ensure evidence aligns with that Statement’s factors. Apply those factors "in accordance with the terms of that Statement ... as in force from time to time" (s 9).

11. Anticipate and pre‑empt timing pitfalls

• Because many factors have strict look‑back windows and cessation rules, ensure dates for onset/worsening are correctly recorded and align the evidence to those temporal thresholds. For example, if repetitive work ceased 45 days before onset, that factor will not be met; find alternative factors or argue for alternative causal links consistent with the parent statutes.

12. Prepare clear medical-legal opinions

• Medical reports should explicitly address the Statement’s elements: confirm electrodiagnostic findings, assess whether a specific factor is present against its defined thresholds, state whether the factor is related to relevant service, and explain contribution/aggravation if factors 23-45 are in play. Avoid generalities; address each element.

13. Record amendment history and applicable version

• Check whether the relevant dates in the claim fall before or after the commencement of the 2020 amendment to the Schedule’s trauma definition. Apply the correct version of the Schedule definition for the claim’s time frame.

14. Administrative strategy

• Where possible, compile multiple lines of evidence to satisfy more than one factor, because multiple corroborating factors strengthen the reasonable hypothesis. If electrodiagnostic testing is absent, arrange it or explain why it was not obtained (bearing in mind s 6(2)(b) is part of the definitional test).

15. Evidence quality and chain of custody

• Ensure records are contemporaneous, complete and authenticated. For exposures dependent on cumulative hours, contemporaneous logs or corroborating third‑party statements are superior to retrospective estimates.

Following this checklist aligns the claim’s evidentiary record with the Statement’s precise requirements. The Statement’s mechanics reward precision: document the exact elements the instrument specifies, tie them to relevant service, and address definitions in Schedule 1 where they are invoked.